A biochemical view: Increase in polyunsaturated fatty acid ω-6/ω-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.

[1]  Da-jun Lou,et al.  Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease. , 2014, Journal of diabetes and its complications.

[2]  M. Serdar,et al.  Comparison of plasma and erythrocyte membrane fatty acid compositions in patients with end-stage renal disease and type 2 diabetes mellitus. , 2014, Chemistry and physics of lipids.

[3]  N. Blau,et al.  Laboratory guide to the methods in biochemical genetics , 2008 .

[4]  S. Piro,et al.  Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[5]  F. Hu,et al.  Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. , 2007, The American journal of clinical nutrition.

[6]  S. Ghezzi,et al.  Fatty acid composition of plasma, blood cells and whole blood: relevance for the assessment of the fatty acid status in humans. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[7]  R. Rodrigo,et al.  Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. , 2004, Clinical science.

[8]  A. Simopoulos,et al.  The importance of the ratio of omega-6/omega-3 essential fatty acids. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.